Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size was valued at US$ 316 million in 2023 and is forecast to a readjusted size of USD 614 million by 2030 with a CAGR of 10.6% during review period.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2019-2030
Global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade Eicosapentaenoic Acid (EPA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KD Pharma, Nippon Suisan Kaisha, Bizen Chemical, AK Biopharm, Maruha Nichiro, Croda Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity 96.5%
Purity 99%
Market segment by Application
Cardiovascular Disease Drugs
Hypolipidemic Drugs
Major players covered
KD Pharma
Nippon Suisan Kaisha
Bizen Chemical
AK Biopharm
Maruha Nichiro
Croda Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade Eicosapentaenoic Acid (EPA), with price, sales quantity, revenue, and global market share of Pharmaceutical Grade Eicosapentaenoic Acid (EPA) from 2019 to 2024.
Chapter 3, the Pharmaceutical Grade Eicosapentaenoic Acid (EPA) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade Eicosapentaenoic Acid (EPA) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Pharmaceutical Grade Eicosapentaenoic Acid (EPA) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade Eicosapentaenoic Acid (EPA).
Chapter 14 and 15, to describe Pharmaceutical Grade Eicosapentaenoic Acid (EPA) sales channel, distributors, customers, research findings and conclusion.